Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods - Bastion Pacific Pty Ltd - 195659

Overview

The Therapeutic Goods Act 1989, enacted in 1989, addresses the regulation of therapeutic goods, including medical devices, within Australia. This legislation was introduced to ensure that therapeutic goods available in Australia are of acceptable quality, safety, and efficacy. The Act is administered by the Australian Government Department of Health, which is tasked with regulating therapeutic goods to protect public health. One of the key policy objectives of the Act is to ensure that the Australian Register of Therapeutic Goods (ARTG) contains accurate and reliable information about the therapeutic goods available in the market. This Gazette, published under section 41GP of the Therapeutic Goods Act 1989, announces the cancellation of an entry for a specific kind of medical device from the ARTG. The cancellation was due to an incorrect certification in the application, as the product in question was determined not to be a medical device. This action ensures the integrity of the ARTG by removing inaccurate entries and maintaining the standards set forth by the Therapeutic Goods Act 1989.

Scope and Application

The Therapeutic Goods Act 1989, under section 41GP, governs the publication of cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods. This particular act applies to the cancellation of entries for specific kinds of medical devices, such as the personal hygiene aid, bib/apron, which was manufactured by Bastion Pacific Pty Ltd and subsequently cancelled due to incorrect certification. The Act encompasses entities that seek to list medical devices in the Australian Register of Therapeutic Goods, which is administered by the Department of Health and Ageing. The cancellation of entries pertains to any incorrect or misleading information in the applications submitted by the sponsors or manufacturers of these medical devices. The jurisdiction of this Act is national, as it is a Commonwealth Act, thereby applying across all states and territories in Australia. There are no stated exclusions, exemptions, or thresholds specified in this particular cancellation notice; however, the scope of the Act might extend to various categories of medical devices through subordinate instruments, which could provide further detail on specific conditions or exceptions applicable to different types of devices.

Key Provisions

The key operative sections of this legislation, specifically section 41GP of the Therapeutic Goods Act 1989, mandate the publication of the cancellation of certain entries for kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG). Under this section, the delegate of the Secretary to the Department of Health and Ageing, in this instance Rodolfo Ferrari, is authorised to make such a publication. The cancellation of the ARTG entry for a personal hygiene aid, bib/apron, with the ARTG number 195659, manufactured by Bastion Pacific Pty Ltd, was published on 28 September 2012, with the cancellation taking effect from 30 November 2012. This Act imposes specific obligations on parties involved with medical devices in Australia. Manufacturers and sponsors must ensure that any product included in the ARTG meets the criteria for classification as a medical device and that the certification process accurately reflects the product's classification and safety. If a product is found not to meet these criteria, the delegate of the Secretary has the authority to cancel the entry from the ARTG, as demonstrated in the case of the personal hygiene aid, bib/apron. Failure to comply with the requirements of the Therapeutic Goods Act 1989 can result in significant consequences. Under the Act, the cancellation of an ARTG entry due to incorrect certification can lead to enforcement actions, including the potential for criminal charges and civil penalties. While the specific penalties for breaches of the Act are not detailed in the provided text, the Act generally allows for substantial fines and, in severe cases, imprisonment. The consequences underscore the importance of adherence to the Act's provisions in maintaining the integrity of the Australian Register of Therapeutic Goods and ensuring public safety.